| Literature DB >> 35280384 |
Linsheng Song1, Xinyi Zhao1, Wenlong Lv2, Hong Pu1, Yifeng Bai3, Shengkun Peng1, Jie Zeng4, Yishuang Wang1, Bo Gong5, Andreas P Kalogeropoulos6.
Abstract
Background: Patients with nonischemic dilated cardiomyopathy (NIDCM) and malignant ventricular arrhythmia (MVA) often have a poor prognosis and a high risk of sudden cardiac death. Although the diagnosis of MVA is straightforward by electrocardiogram (ECG), the underlying abnormalities of ventricular mechanics in these patients are unknown. This study aims to preliminarily explore the value of cardiac magnetic resonance feature tracking (CMR-FT) for MVA in dilated cardiomyopathy.Entities:
Keywords: Dilated cardiomyopathy; malignant arrhythmia; tracking; ventricular strain
Year: 2022 PMID: 35280384 PMCID: PMC8908127 DOI: 10.21037/atm-22-660
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 1Feature-tracking analysis was performed on routine cardiac cine images (short-axis views and two-, three-, and four-chamber views). In long-axis and short-axis views, the endocardial and epicardial contours were automatically detected with manual correction. The deeper orange and blue indicate poor heart function. MRI, magnetic resonance imaging; Myo, myocardial.
Figure 2Patient flowchart. ECG, electrocardiogram; BNP, brain natriuretic peptide.
Clinical characteristics of all patients
| Variable | All patients (n=161) | MVA group (n=54) | Non-MVA group (n=107) | P value |
|---|---|---|---|---|
| Demographics | ||||
| Sex | 0.46 | |||
| Female | 84 [52] | 34 [63] | 50 [47] | |
| Male | 77 [48] | 20 [37] | 57 [53] | |
| Age (y) | 55±13 | 55±12 | 54±13 | 0.47 |
| Heart rate (beata/min) | 93±12 | 108±11 | 76±13 | <0.001* |
| Weight (kg) | 71±11 | 73±10 | 72±12 | 0.23 |
| Body mass index (kg/m2) | 27.2±4.1 | 27.4±4.3 | 27.1±3.9 | 0.56 |
| Comorbidities | ||||
| Hypertension | 161 [43] | 54 [10] | 107 [33] | 0.68 |
| Diabetes | 161 [39] | 54 [10] | 107 [29] | 0.16 |
| CKD | 161 [18] | 54 [8] | 107 [10] | 0.22 |
Data are displayed as mean ± standard deviation or frequency [%]. *, statistically significant difference. MVA, malignant ventricular arrhythmia; CKD, chronic kidney disease.
Intraclass correlation coefficient of CMR-FT 3D strain parameters in the NIDCM group
| Variable | ICC | ICC 95% CI |
|---|---|---|
| GLS | 0.938 | 0.745–0.985 |
| GCS | 0.925 | 0.741–0.982 |
| GRS | 0.942 | 0.758–0.986 |
ICC, intraclass correlation coefficient; CI, confidence interval; GLS, global longitudinal strain; GCS, lobal circumferential strain; GRS, global radial strain; NIDCM, nonischemic dilated cardiomyopathy; CMR-FT, cardiac magnetic resonance feature tracking.
Comparison of parameters between the MVA group and the non-MVA group
| Variable | MVA (n=54) | Non-MVA (n=107) | P value |
|---|---|---|---|
| Clinical parameters | |||
| BNP (pg/mL) | 2,152.9 (1,843.8–2,568.0) | 357.1 (148.3–667.6) | <0.001* |
| Tp-Te (ms) | 103.3 (96.7–119.2) | 83.3 (70.0–90.0) | <0.001* |
| CMR parameters | |||
| LVEF (%) | 23.0 (20.0–26.0) | 30.0 (26.0–34.0) | <0.001* |
| GLS (%) | −6.6 (−5.2 to −8.3) | −10.2 (−8.5 to −11.8) | <0.001* |
| GCS (%) | −6.7 (−5.2 to −8.3) | −10.3 (−8.5 to −12.2) | <0.001* |
| GRS (%) | 6.8 (4.7–10.0) | 12.3 (8.3–15.5) | <0.001* |
Data are displayed as medians, with interquartile ranges in parentheses. *, statistically significant difference. MVA, malignant ventricular arrhythmia; BNP, brain natriuretic peptide; LVEF, left ventricular ejection fraction; Tp-Te, Tpeak-Tend interval; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain.
ROC analysis curve of BNP, LVEF, Tp-Te, GLS, GCS, and GRS in the MVA group
| Variable | Cut-off | AUC | 95% CI | Sensitivity | Specificity |
|---|---|---|---|---|---|
| Clinical parameters | |||||
| BNP (pg/mL) | 1,294 | 0.959 | 0.931–0.987 | 0.889 | 0.888 |
| Tp-Te (ms) | 96 | 0.859 | 0.797–0.921 | 0.804 | 0.791 |
| CMR parameters | |||||
| LVEF (%) | 25.5 | 0.672 | 0.637–0.808 | 0.704 | 0.710 |
| GLS (%) | −8.375 | 0.795 | 0.725–0.866 | 0.778 | 0.757 |
| GCS (%) | −8.305 | 0.802 | 0.731–0.872 | 0.796 | 0.776 |
| GRS (%) | 9.105 | 0.754 | 0.676–0.832 | 0.741 | 0.692 |
ROC, receiver operating characteristic; MVA, malignant ventricular arrhythmia; BNP, brain natriuretic peptide; LVEF, left ventricular ejection fraction; Tp-Te, Tpeak-Tend interval; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain; AUC, area under the receiver operating characteristic curve; CI, confidence interval.
Figure 3(A) ROC curves for predicting MVA in NIDCM patients: BNP: AUC =0.959; Tp-Te: AUC =0.859; LVEF: AUC =0.672; GLS: AUC =0.795; GCS: AUC =0.802; GRS: AUC =0.754. (B) ROC curves for predicting MVA in NIDCM patients: GLS + GCS + GRS: AUC =0.810; GLS + GCS: AUC =0.810; GCS + GRS: AUC =0.802; GLS + GRS: AUC =0.787. The yellow line (GLS + GCS + GRS) coincides with the green line (GLS + GCS). ROC, receiver operating characteristic; MVA, malignant ventricular arrhythmia; NIDCM, nonischemic dilated cardiomyopathy; BNP, brain natriuretic peptide; Tp-Te, Tpeak-Tend interval; LVEF, left ventricular ejection fraction; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain.
ROC analysis curve of CMR-FT characteristics of patients with MVA
| Variable | AUC | 95% CI | Sensitivity | Specificity |
|---|---|---|---|---|
| GLS | 0.795 | 0.725–0.866 | 0.778 | 0.757 |
| GCS | 0.802 | 0.731–0.872 | 0.796 | 0.776 |
| GRS | 0.754 | 0.676–0.832 | 0.741 | 0.625 |
| GLS+GCS+GRS | 0.810 | 0.742–0.877 | 0.944 | 0.701 |
| GLS+GCS | 0.810 | 0.742–0.877 | 0.926 | 0.682 |
| GCS+GRS | 0.802 | 0.731–0.872 | 0.926 | 0.692 |
| GLS+GRS | 0.787 | 0.715–0.859 | 0.889 | 0.682 |
ROC, receiver operating characteristic; MVA, malignant ventricular arrhythmia; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain; AUC, area under the receiver operating characteristic curve; CMR-FT, cardiac magnetic resonance feature tracking; CI, confidence interval.